SCHEMBL4984535

SCHEMBL4984535

CC(C)CCOC(=O)CC(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
MAPK1 P28482 3/20 0.50
MEN1 O00255 3/20 0.50
KDM4E B2RXH2 3/20 0.50
HPGD P15428 2/20 0.50
MAPT P10636 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
CES1 P23141 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CYP19A1 P11511 1/20 0.48
PPARG P37231 1/20 0.47
NPC1 O15118 3/20 0.46
RAB9A P51151 2/20 0.46
HSD17B10 Q99714 4/20 0.46
ALDH1A1 P00352 2/20 0.46
THRB P10828 1/20 0.46
TSHR P16473 1/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28014921 0.84 KMT2A (0.50) KMT2AMAPK1MEN1KDM4EHPGD
SCHEMBL4977454 0.83 KMT2A (0.53) KMT2AMAPK1MEN1KDM4EHPGD
SCHEMBL2375373 0.81 LMNA (0.62) KMT2AMAPK1MEN1KDM4EHPGD
SCHEMBL29549033 0.81 TDP1 (0.60) KMT2AMAPK1MEN1KDM4EHPGD
SCHEMBL28740463 0.80 KMT2A (0.53) KMT2AMAPK1MEN1KDM4EHPGD
SCHEMBL16624895 0.80 L3MBTL1 (0.55) KMT2AMAPK1MEN1HPGDMAPT
Benzoic Acid 1-(3-Methyl)Butyl Ester SCHEMBL28250108 0.80 LMNA (0.65) KMT2AMAPK1KDM4ESMN1; SMN2TDP1
Benzoic Acid 1-(3-Methyl)Butyl Ester SCHEMBL132524 0.80 LMNA (0.65) KMT2AMAPK1KDM4ESMN1; SMN2TDP1
SCHEMBL7678585 0.80 TDP1 (0.57) KMT2AMAPK1MEN1KDM4EHPGD
Propiophenone SCHEMBL28521313 0.79 SMN1; SMN2 (0.49) KMT2AMAPK1MEN1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080050319-A1 Benzylidene-Alpha-Dicarbonyl Compounds as Novel Uv Absorbers SYMRISE GMBH & CO. KG (DE) 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080050319-A1 Benzylidene-Alpha-Dicarbonyl Compounds as Novel Uv Absorbers C1R, C9, DECR1 KMT2A 3126/4885MAPK1 4419/4885MEN1 934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.